The Journal retracts the 2 June 2023 article cited above.
Following publication, concerns were raised regarding the contributions and affiliations of the authors of the article. Image duplication concerns were also identified with Figure 8. Our investigation, conducted in accordance with Frontiers policies, confirmed a serious breach of our authorship policies and of publication ethics.
This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication is recorded by the publisher.
Summary
Citation
Frontiers Editorial Office (2025) Retraction: Identification of novel candidate targets for suppressing ovarian cancer progression through IL-33/ST2 axis components using the system biology approach. Front. Mol. Biosci. 12:1605599. doi: 10.3389/fmolb.2025.1605599
Received
03 April 2025
Accepted
03 April 2025
Published
10 April 2025
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2025
Updates
Copyright
© 2025 Frontiers Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.